– Alphyn Biologics presenta nuevos datos de un ensayo de fase 2a que muestran una mejora significativa de la dermatitis atópica leve a moderada – Mejoras estadísticamente significativas en las puntuaciones IGA (Investigator Global Assessment) y EASI (Eczema Area and Severity Index) -…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.